Logo
News
Feb 01, 2026

Paean Bio approved for domestic Phase 1/2a mitochondrial therapeutic trials

Paean Bio approved for domestic Phase 1/2a mitochondrial therapeutic trials
8 views
Share:

Related News

More Updates From Our Research Journey

News Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Feb 01, 2026

Source: http://m.biospectator.com/view/news_view.php?varAtcId=8243

Read More
News World's first clinical trial for mitochondrial therapeutic... From immune cell therapy to anticancer drugs

World's first clinical trial for mitochondrial therapeutic... From immune cell therapy to anticancer drugs

Feb 01, 2026

Source: https://www.hankyung.com/it/article/202110202008i

Read More
News Paean Bio "Joint research on mitochondrial therapeutics with two overseas pharma companies"

Paean Bio "Joint research on mitochondrial therapeutics with two overseas pharma companies"

Feb 01, 2026

Source: https://www.donga.com/news/It/article/all/20220423/113035474/1?ref=main

Read More
News [Promising Company] Paean Biotechnology embarks on world's first mitochondrial clinical trial

[Promising Company] Paean Biotechnology embarks on world's first mitochondrial clinical trial

Feb 01, 2026

Source: https://www.hankyung.com/it/article/202112071993i

Read More
Logo

Headquarter : 108SB, DaeduckBiz Center
17 Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea

Mail : info@paeanbio.com

Phone : 042-334-7378 | Fax : 042-334-7096

Navigation

Other

Copyrights © 2025 All Rights Reserved by PAEAN BIOTECHNOLOGY